Published in Drug Week, October 8th, 2004
Biodyne Inc. is a Houston-based, privately held, biomedical development firm, and has engaged Biodyne in the development and implementation of its clinical neurotherapy services to be delivered by Qbit's subsidiary, Physical Therapy Associates, later this year. The initial focus for these therapies is the treatment of attention deficit disorder (ADD), thus providing an alternate to treatment with psycho-stimulants such as Ritalin. A quote from a recent scientific animal study points to the potential negative effects of the extensive use of the psycho-stimulant, Ritalin, to treat attention...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.